Introduction
Several prospective epidemiological studies, set up mainly to examine the association of baseline blood concentration of cholesterol with subsequent rates of coronary heart disease, have also examined its association with subsequent rates of cancer.'-14 Most'" but not all'3 14 have found an inverse relation between cholesterol concentration and the subsequent risk of cancer. This seems to be due, at least in part, to a lowering effect of preclinical cancer on cholesterol concentration,2-5 1 but other factors may also contribute to the inverse association. '5 16 In China there are particularly high death rates from diseases of the liver. A prospective observational study in a Chinese population'2 (in which the mean cholesterol concentration is unusually low by Western standards) found a significant inverse association between blood concentration of cholesterol and subsequent mortality from non-malignant liver disease or from liver cancer, although not from other types of cancer. More recently a significant excess risk of death from liver cancer and chronic liver disease has been reported among North Americans with a low blood cholesterol concentration. '6 In China most deaths from liver disease are due to chronic infection with the hepatitis B virus. '7 18 We investigated the association between low blood cholesterol concentration and liver disease'2 16 by studying blood lipid concentrations among middle aged men in rural China, of whom about 15% were known to be carriers of the hepatitis B virus. '9 Subjects and methods
BLOOD SAMPLES
A large geographical correlation survey in rural China was conducted between September and December 1983.'9 Sixty five counties throughout China were selected for the survey on the basis of wide variations in the 1973-5 death rates from seven major types of cancer (including liver cancer).20 Two rural villages in different communes within each county were randomly selected, and a random sample stratified for age, consisting of about 25 apparently healthy men and 25 women (aged years) from each village, was studied.
A sample of fasting venous blood (10 ml) was collected from each subject into a vacutainer. On the day of collection all blood samples were centrifuged in the local field survey centres to separate plasma from red blood cells, and 4 ml of plasma containing 20 
Mathematical details
In each village the excess lipid value for each subject is defined as the difference between the subject's lipid value and the average for his or her village (S2 denotes the sum of the squares of these excesses, all divided by (N-1), where N is the number of people in the village). For each village the numerator is defined as the sum of the excesses among the infected subjects and the denominator (D) as the number infected multiplied by the proportion uninfected, with the variance of the numerator being S2 multiplied by D. Within any one village the difference in average lipid values between infected and uninfected subjects is the ratio of the numerator to the denominator (with standard deviation given by the ratio of the square root of the variance to the denominator26). By combining data from several villages the permutational estimate of the difference in lipid values between infected and uninfected subjects in the same village is simply the ratio of the sum of the numerators to the sum of the denominators (with standard deviation given by the ratio of the square root of the sum of the variances to the sum of the denominators).
In the results values are given with 1 SD or with 95% confidence intervals. Trend tests across age groups for lipids and for prevalences of hepatitis B were performed with standard linear regression analysis.
Results
In this rural Chinese population the prevalence of infection with hepatitis B virus was high: of 1556 samples, 238 (15%) were positive for hepatitis B surface antigen-that is, they were chronic carrierswith the prevalences in particular villages ranging from 0% to 54% (table I ). An additional 794 (51%) had evidence of past infection with hepatitis B virus-that is, they were positive for hepatitis B core antibody but negative for hepatitis B surface antigen-with the prevalences ranging from 6% to 100%. (The overall prevalence of past infection is probably greater than this, however, as hepatitis B core antibody may not be detectable many years after infection.) The overall mean plasma concentration of cholesterol was low by Westem standards at 2-59 mmol/l (see discussion). Apolipoprotein B and apolipoprotein A I concentrations were also low, with mean values of 0-51 g/l and 1-39 g/l, respectively. There was about a twofold variation among the villages with respect to the mean plasma concentrations of cholesterol, apolipoprotein B, and apolipoprotein A I (table I) . Table I shows the prevalence of hepatitis B infection and the mean plasma concentrations of total cholesterol, apolipoprotein B, and apolipoprotein A I by five year age groups for the whole study population. The prevalence of hepatitis B surface antigen, reflecting chronic hepatitis B virus infection, seemed slightly higher among younger than among older people, whereas the converse tended to be true for past infection with hepatitis B virus (p<0-01). Plasma concentrations of cholesterol and apolipoprotein B tended to increase with age, especially after 50 years (cholesterol: p < 0 001; apolipoprotein B: p < 0 01), but apolipoprotein A I concentrations did not. Table II shows the mean plasma concentrations of total cholesterol, apolipoprotein B, and apolipoprotein A I according to presence of hepatitis B virus, subdivided by the underlying prevalence of chronic hepatitis B. Figures 1 and 2 also show the relation of cholesterol and apolipoprotein B concentrations to chronic infection with hepatitis B virus both within and between villages. There was a positive geographical correlation between the prevalence of chronic hepatitis B and the mean plasma concentrations of total cholesterol and apolipoprotein B. But, within particular prevalences of hepatitis B virus infection, the plasma concentrations of cholesterol, apolipoprotein B, and apolipoprotein A I were generally lower among carriers of hepatitis B virus than among non-carriers. The overall differences for cholesterol and apolipoprotein B concentrations were significant after age and village membership were considered. On average, the concentration of cholesterol was 4-2% (0 11 mmol/l) lower (95% confidence interval 0 6%to 8 0%, (001 to 0 21 mmol/l), p < 0 05) among carriers, while for apolipoprotein B it was 7.0% (0-036 g/l) lower (2-8% to 11.2% (0-014 to 0-058 g1l), p<0-001). Among people who were noncarriers-that is, negative for hepatitis B surface antigen-there were no significant associations of lipid concentrations with past infection with hepatitis B virus, as assessed by the existence of hepatitis B core antibody. This was true for total cholesterol concentration (overall adjusted difference between non-carriers who were positive for hepatitis B core antibody and those who were negative for it was 0-02 mmol/ (-0'04 to 0-08 mmolIl), for apolipoprotein B concentration 0-006 g/l (-0-006 to 0-018 g/l), and for apolipoprotein A I concentration 0-024 g/l (-0003 to 0-051 g/l)). The 4% difference in cholesterol concentrations between carriers and non-carriers of hepatitis B virus is only half the size of the difference (8/0% for liver cancer) observed in our previous report between those who actually died of liver cancer or chronic nonmalignant liver disease and those who did not.'2 But the carriers included in this study had, in general, no clinically apparent evidence of liver damage. So, although this apparent discrepancy may be due to chance (as there is overlap between the 95% confidence intervals of the two differences), it may also reflect heterogeneity in the severity of the liver damage of carriers, if the severity of damage correlates both with the reduction in cholesterol concentration and with the risk of death. This possibility is supported by a recent study in which lipoprotein(a) concentration was significantly reduced in patients with cirrhosis, the size of the reduction in lipoprotein(a) concentration being correlated with the severity of the cirrhosis."
The low mean cholesterol concentration in China has been documented in previous studies. The measured plasma concentration of cholesterol in the present samples was only 2-59 mmol/l, which is about half that seen in most Westem populations. This figure is a slight underestimate, however, compared with the results ofprevious pooled analyses on the same samples made seven years ago which yielded a mean of 3 30 mmol/l.'9 The mean apolipoprotein B concentration was also significantly lower in the present analysis than previously. This decrease after seven years is unlikely to be attributable to changes in laboratory methods as the measurement of apolipoprotein B was done in the same laboratory with the same method but may instead reflect the effects of storage and handling procedures. This should not, however, have influenced the relative difference found in lipid concentrations between carriers and non-carriers.
COMPARISONS BETWEEN AND WITHIN POPULATIONS
In this study there was a negative correlation between chronic infection with hepatitis B virus and blood concentrations of cholesterol (and apolipoprotein B) when people living in the same village were compared with each other, but the correlation was reversed when average values for different villages were compared with each other. An underlying cause for the substantial differences in the mean lipid concentrations between the villages is probably the differences in nutritional practices between them9 but not the differences in the prevalence of chronic hepatitis B, for even among non-carriers these differences in lipid concentration remain. Differences in nutritional practices and mean lipid concentrations are probably-associated with differing degrees of urbanisation and industrialisation,'9 but why they are correlated with the prevalence of hepatitis B infection and whether this is coincidental are not clear. Correlations between populations based on average measures in groups are subject to the "ecological fallacy" (whereby these correlations may not represent the correlations that would be seen among individual subjects'4); the epidemiological strengths and weaknesses of comparisons of individual subjects within one population and of comparisons of different geographically defined populations have already been discussed in the context of this particular study. ' Thirty eight women attended for follow up. Three women had experienced symptoms which had prompted them to contact their family doctor, while 23 had been able to return to normal daily activities immediately; in the remainder the median duration of inactivity was 3 (1-7) days. Haemoglobin concentration showed a median decrease of 2 g/l, with values ranging from a decrease of 17 g/l to an increase of 9 g/l. No further women required either elective or emergency uterine curettage, so overall complete uterine evacuation occurred in 41 women.
Comment
This report suggests that prostaglandin analogues may be practical alternatives to surgical uterine evacuation in managing spontaneous incomplete or inevitable miscarriage; the ability of these drugs to stimulate uterine contractility is well known.3 Similar high success rates occur in medical abortion (sequential treatment with an antigestagen and a prostaglandin), which may mimic the physiological events of spontaneous miscarriage.' Although only 88% of women were seen at follow up, none of the women who failed to attend requested treatment from her general practitioner or was readmitted to hospital (no other hospital in this area provides gynaecological services). The procedure seemed to be well tolerated: most women were rapidly able to return to normal daily activities and consultation rates with family doctors were low.
This 
